Ghani Dairies Ltd. (GDL)
Pakistan Stock Exchange (PSX) · Pakistan · prices in PKR · close of 16 Nov 2026
Key indicators
| Last close | PKR 17.87 |
|---|---|
| 52-week range | 16.01 – 33.00 |
| Return, 1 month / 3 months | −3.6% / +2.4% |
| Return, 1 year / 3 years | – / – |
| Trend | – |
| RSI (14) | – |
| Volatility (1 year) | 44.6% |
| Worst drawdown (1 year) | -44.4% |
| Average daily value traded | 15.13M PKR |
| Dividend yield | – |
Market X-Ray price-based
Fair value limited data
Five-year price chart navy: price · brown: 200-day average · blue band: fair value range
About the company
Ghani Dairies Limited is a dairy company whose main business is producing and selling raw milk. Raw milk is the untreated milk drawn from dairy animals, and it serves as the basic ingredient from which drinking milk and other dairy products are made. The company carries on this production and sale as its principal activity.
The shares are listed on the Pakistan Stock Exchange (PSX) under the code GDL, and the price on this page is in Pakistani rupees (PKR). Dividend data for this stock is not available yet. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Ghani Dairies Ltd. (GDL) trades on the Pakistan Stock Exchange (PSX) in Pakistan. It last closed at PKR 17.87 on 16 November 2026.
Its price-based Market X-Ray is 44 out of 100 (a weak price profile), ranking 369 of 568 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Our limited-data fair value is PKR 20.08 (Fair, +12.4% to fair value). It averages 3 models built from the earnings and sales this exchange publishes. Their weights were fitted to a professional consensus-style valuation of Pakistani stocks and checked on stocks left out of the fit, but no analyst forecasts are used, so read it as a rough range.
The five lenses in numbers each metric is ranked against the other stocks on Pakistan Stock Exchange (PSX)
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 21 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | – | ||
| From 52-week high | -39.9% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 2.4% | ||
| 6-month return | -12.7% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 53 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.4% | ||
| Liquidity | 66 · Fair | Moderate trading activity. | |
| Average daily value traded | 15.13M PKR | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends, last 5 | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +4.0% |
|---|---|
| 1 month | −3.6% |
| 3 months | +2.4% |
| 6 months | −12.7% |
| 1 year | – |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 17.88 / – |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | – |
Technical summary
Fair value models PSX income statement only (no balance sheet or cash flow): only earnings, sales and dividend models can be built
| P/E multiple | PKR 21.24 |
|---|---|
| P/S multiple | PKR 19.17 |
| P/E on average earnings | PKR 19.84 |
How to read this report
Every number comes from end-of-day prices and dividends and the earnings and sales this exchange publishes. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Pakistan Stock Exchange (PSX); it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.